Microsoft and John Hopkins Medication proclaims five-year settlement
Microsoft Azure becomes the preferred cloud platform for Johns Hopkins in Health Precision Medicine Initiative
Microsoft Corp. and Johns Hopkins medicine (JHM) announced a five-year relationship focused on Microsoft's Azure, an analytics tool that supports new discoveries as part of JHM's inHealth Precision Medicine initiative.
The work will combine JHM's global research expertise with the power of Microsoft Azure and its AI capabilities to advance JHM's discoveries that benefit personalized healthcare. JHM retains complete control over its data.
inHealth embodies Johns Hopkins' commitment to precision medicine by using new tools to understand and manage patient health shaped by their broader medical history and environment. This program combines JHM's longstanding leadership in healthcare research and delivery with the expertise of the Johns Hopkins Bloomberg School of Public Health, the Johns Hopkins Whiting School of Engineering and the Johns Hopkins University Applied Physics Lab.
To support inHealth, JHM has set up 16 competence centers for precision medicine, in which researchers track breakthroughs in numerous clinical pictures such as prostate cancer and multiple sclerosis. JHM is aiming for 50 centers in the next five years.
"Johns Hopkins is committed to being a leader in precision medicine, and our relationship with Microsoft will help us achieve that goal," said Dr. Paul B. Rothman, CEO of JHM, and Dr. Frances Watt Baker, and Lenox D. Baker Jr, MD, Dean of the Medical School. "Using Azure will improve our ability to develop innovative solutions and treatments for our patients. We look forward to working with Microsoft to push the boundaries of science and medicine even further."
The ethical use of patient data is a cornerstone of all JHM partnerships with patients, including this important work with Microsoft in precision medicine. All projects comply with all applicable data protection regulations, and JHM maintains strict control over all data, including the use of its Institutional Review Board and its internal Data Trust Council, which checks data usage in JHM.
"It is a privilege to work with many of JHM's leading doctors, scientists and engineers worldwide who are using Microsoft Azure and its AI and machine learning capabilities to support some of the most advanced research and breakthroughs in precision medicine," said Gregory Moore, MD, PhD, corporate vice president of Microsoft Health.
"I am inspired by the collaboration and their brave goals to improve health for all by bringing together some of the world's best brains in medicine and technology to enable the future of medical science innovation."
JHM previously used Microsoft services when JHM developed its pioneering Precision Medicine Analytics Platform (PMAP), a highly innovative data platform that enables information from a variety of sources to be collected and analyzed in a secure environment. This new agreement enables inHealth to expand the use of other Microsoft resources such as advanced services, AI, machine learning and analytics.
